Vimarsana
Biggest News Aggregation in the World

Page 38 - Service Testing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Service Testing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Service Testing Today - Breaking & Trending Today

Acelyrin Shares Fall 11%, Programming Error Found in Arthritis Drug Trial - Vimarsana News

Acelyrin Shares Fall 11%, Programming Error Found in Arthritis Drug Trial

By Ben Glickman Shares of Acelyrin fell on Monday after the company said there was a programming error in its drug trial of a treatment for psoriatic...

Alterity Therapeutics ADRs Shares Dive 31% on Raised Capital - Vimarsana News

Alterity Therapeutics ADRs Shares Dive 31% on Raised Capital

By Denny Jacob American depositary receipts of Alterity Therapeutics dived 31% to $1.64 following the raising of capital to provide ongoing funding to...

Entrada Therapeutics Shares Tumble 27% After FDA Keeps Clinical Hold - Vimarsana News

Entrada Therapeutics Shares Tumble 27% After FDA Keeps Clinical Hold

By Colin Kellaher Entrada Therapeutics shares slid on Wednesday after the biopharmaceutical company said the Food and Drug Administration wouldn't lift the...

Bayer Shares Tumble After Clinical Trial Failure, Loss in Roundup Case - Vimarsana News

Bayer Shares Tumble After Clinical Trial Failure, Loss in Roundup Case

Company halts study for blood-thinning drug, is told to pay $1.56 billion in lawsuit relating to weedkiller

Source: wsj.com
Landos Biopharma Shares Rise 10% After Positive Trial Data for NX-13 - Vimarsana News

Landos Biopharma Shares Rise 10% After Positive Trial Data for NX-13

By Chris Wack Landos Biopharma shares were up 10% to $4.31 after the company published positive safety, tolerability, pharmacokinetic and clinical efficacy...